Eurizon Capital SGR SpA’s Dr. Reddy's Laboratories RDY Stock Holding History

Eurizon Capital SGR SpA’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	+17,434	New	+$235K	﹤0.01%	703

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Eurizon Capital SGR SpA's RDY Position: Q2 2026 in Review

Eurizon Capital SGR SpA opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 17,434 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #703 among its holdings.

238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Eurizon Capital SGR SpA held 17,434 shares of Dr. Reddy's Laboratories worth $259K as of Q2 2026.
Dr. Reddy's Laboratories was a new Eurizon Capital SGR SpA position in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #703 holding.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.